Logo image of KDK

KODIAK AI INC (KDK) Stock Fundamental Analysis

USA - NASDAQ:KDK - KYG330331045 - Common Stock

9.1 USD
-0.15 (-1.62%)
Last: 10/14/2025, 12:59:54 PM
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to KDK. KDK was compared to 0 industry peers in the Unkown industry. KDK has a bad profitability rating. Also its financial health evaluation is rather negative. KDK does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

KDK had positive earnings in the past year.
KDK had a negative operating cash flow in the past year.
KDK Yearly Net Income VS EBIT VS OCF VS FCFKDK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 5M 10M 15M 20M 25M

1.2 Ratios

Industry RankSector Rank
ROA 2.91%
ROE 3.06%
ROIC N/A
ROA(3y)2.64%
ROA(5y)N/A
ROE(3y)2.76%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
KDK Yearly ROA, ROE, ROICKDK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

KDK does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
KDK Yearly Profit, Operating, Gross MarginsKDK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024

More info and screens

2

2. Health

2.1 Basic Checks

KDK has about the same amout of shares outstanding than it did 1 year ago.
Compared to 1 year ago, KDK has an improved debt to assets ratio.
KDK Yearly Shares OutstandingKDK Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 20M 40M 60M
KDK Yearly Total Debt VS Total AssetsKDK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

KDK has an Altman-Z score of 49.48. This indicates that KDK is financially healthy and has little risk of bankruptcy at the moment.
A Debt/Equity ratio of 0.02 indicates that KDK is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Altman-Z 49.48
ROIC/WACCN/A
WACCN/A
KDK Yearly LT Debt VS Equity VS FCFKDK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 100M 200M 300M 400M 500M

2.3 Liquidity

A Current Ratio of 0.23 indicates that KDK may have some problems paying its short term obligations.
KDK has a Quick Ratio of 0.23. This is a bad value and indicates that KDK is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.23
Quick Ratio 0.23
KDK Yearly Current Assets VS Current LiabilitesKDK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 500K 1M 1.5M 2M

More info and screens

0

3. Growth

3.1 Past

KDK shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -42.98%.
EPS 1Y (TTM)-42.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-94.97%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 35.00, KDK can be considered very expensive at the moment.
When comparing the Price/Earnings ratio of KDK to the average of the S&P500 Index (27.34), we can say KDK is valued slightly more expensively.
Industry RankSector Rank
PE 35
Fwd PE N/A
KDK Price Earnings VS Forward Price EarningsKDK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
KDK Per share dataKDK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for KDK!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

KODIAK AI INC

NASDAQ:KDK (10/14/2025, 12:59:54 PM)

9.1

-0.15 (-1.62%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)08-04 2025-08-04
Earnings (Next)11-10 2025-11-10
Inst Owners83.41%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner Change92.28%
Market Cap2.20B
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 35
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 4.11
P/tB 4.11
EV/EBITDA N/A
EPS(TTM)0.26
EY2.86%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS2.21
TBVpS2.21
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.91%
ROE 3.06%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)2.64%
ROA(5y)N/A
ROE(3y)2.76%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.23
Quick Ratio 0.23
Altman-Z 49.48
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-42.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-94.97%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-457.03%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y31.25%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y31.25%
OCF growth 3YN/A
OCF growth 5YN/A